Caitong International Asset Management’s Century Therapeutics IPSC Stock Holding History

Caitong International Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86	Buy	+35	New	+$80	﹤0.01%	2223

Other funds holding IPSC

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Caitong International Asset Management's IPSC Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Century Therapeutics (IPSC) in Q2 2026: 35 shares worth $86. The stake represents ﹤0.01% of the portfolio and ranks #2223 among its holdings.

100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Caitong International Asset Management held 35 shares of Century Therapeutics worth $86 as of Q2 2026.
Century Therapeutics was a new Caitong International Asset Management position in Q2 2026.
Century Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2223 holding.
100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.